EditorialPublished 30 Sep 2024
Unlocking Tumor Biology: Game-Changing Therapies for Chordomas
Service of Oral Pathology, Federal University of Para, Brazil
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chordomas are rare, malignant bone tumors that arise from remnants of the notochord, primarily affecting the axial skeleton. Despite their slow growth, they present significant clinical challenges due to their proximity to critical structures, high recurrence rates, and resistance to conventional therapies. Recent advancements in molecular biology and tumor genetics have led to the development of novel therapeutic approaches aimed at targeting key biological pathways driving chordoma progression. This article explores the latest breakthroughs in chordoma research, including immunotherapies, targeted molecular agents, and precision medicine strategies. By unlocking the intricacies of tumor biology, these game-changing therapies offer new hope for improving patient outcomes and mitigating the burden of this rare and challenging disease.
Subjects
Oncology & CancerOrthopaedicsAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Orthopedic Oncology
- SubjectOncology & Cancer
- SubjectOrthopaedics
- BylineArticles whose byline prints “Zachary Kamrava”